Capital World Investors
CAI

Capital World Investors’s Caris Life Sciences CAI Stock Holding History

Capital World Investors’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.6M Buy
1,213,272
+33,099
+3% +$592K ﹤0.01% 553
2026
Q1 		$21.1M Buy
+1,180,173
New +$25.8M ﹤0.01% 529
2025
Q3 		– Sell
-999,945
Closed -$26.7M – 617
2025
Q2 		$26.7M Buy
+999,945
New +$26.9M ﹤0.01% 459

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors's CAI Position: Q2 2026 in Review

Capital World Investors increased its Caris Life Sciences (CAI) stake by 2.8% in Q2 2026, buying an estimated $592K and bringing the position to 1,213,272 shares worth $21.6M. The position accounts for ﹤0.01% of the portfolio, ranked #553.

Capital World Investors first reported a position in CAI in Q2 2025 and has held it in 3 quarters since. The position peaked at $26.7M in Q2 2025. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Capital World Investors held 1,213,272 shares of Caris Life Sciences worth $21.6M as of Q2 2026.
  • Capital World Investors bought 33,099 Caris Life Sciences shares in Q2 2026, an estimated $592K.
  • Caris Life Sciences made up ﹤0.01% of Capital World Investors's portfolio in Q2 2026, its #553 holding.
  • Capital World Investors first reported a position in Caris Life Sciences in Q2 2025 and has held it in 3 quarters since.
  • Capital World Investors's Caris Life Sciences position peaked at $26.7M in Q2 2025.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.